Siemens Healthcare GmbH services

The PRECISION Study was a multicenter, post-market registry of robotic PCI using the Corindus CorPath 200 System. The purpose of the study was to collect data on the routine patterns of use, safety and effectiveness, including the clinical and technical performance of the CorPath 200 System, in the delivery and manipulation of coronary guidewires and stent/balloon catheters during PCI procedures.

The pivotal, multi-center PRECISE trial demonstrated the safety and feasibility of the remote-controlled CorPath 200 System for use during PCI. The study met its clinical and technical endpoints, with the operator experiencing a significant reduction in radiation exposure. There were no reports of device-related complications and an overall clinical success rate of 97.6%. The average radiation exposure to the interventional cardiologist decreased by 95.2%, in contrast to levels reported during standard interventions.

The CorPath Vascular Robotic Program is the first and only robotic program for interventional cardiologists. Corindus is investing in next-generation technology and clinical research to explore new frontiers of vascular robotics, along with additional disease segments.

Today, the service experience goes above and beyond pure maintenance. Service can make the difference to your daily operations and help you evolve. This is why we keep innovating our portfolio and team up with you for enhanced efficiency and optimized clinical outcomes. As our world becomes more connected each day, we put special focus on adding new services to our digital offerings so we can fulfill your requirements better and faster. With our services, we are by your side whenever you need us. Always on. Always in touch.